陈公琰, 洪璇. 血管内皮生长因子与肺癌的关系 [J]. 中华肿瘤杂志, 2005(8):449.doi: 10.3760/j.issn:0253-3766.2005.08.001.
|
Lutsenko S V, Kiseler S M, Severin S E. Molecular mechanisms of tumor angiogenesis [J]. Biochemistry(Moscow), 2003.286.
|
陆恩词. 肺癌患者血清VEGF的表达及意义 [J]. 实用临床医药杂志, 2009(4):82.doi: 10.3969/j.issn.1672-2353.2009.07.030.
|
朱小生, 马倩, 操乐杰. 肺癌患者血管内皮生长因子和内皮抑素水平变化及意义 [J]. 实用临床医药杂志, 2008(6):1.
|
李圣青. 肿瘤抗血管生成治疗研究新进展 [J]. 实用临床医药杂志, 2008(6):9.
|
陈寿松, 陈昕薇, 肖同浩. COX-2、PCNA、VEGF和MVD在非小细胞肺癌中的表达及其临床意义 [J]. 华南国防医学杂志, 2008(4):21.
|
刘孝民, 李志娟, 王红岩. VEGF与非小细胞肺癌预后的相关性研究 [J]. 临床肿瘤学杂志, 2007(2):88.doi: 10.3969/j.issn.1009-0460.2007.02.003.
|
刘颖, 周清华, 陆艳蓉. 非小细胞肺癌患者血清中内皮抑素、VEGF水平及其与临床病理生理特征的关系 [J]. 中国肺癌杂志, 2004(1):50.
|
Hasegawa Y, Takanashi S, Okudera K. Vascular endothelial growth factor level as a prognostic determinant of small cell lung cancer in Janpaneas patients [J]. Internal Medicine, 2005(1):26.doi: 10.2169/internalmedicine.44.26.
|
王萌, 陈公琰, 蔺铁. Survivin、VEGF在非小细胞肺部中的表达及相关性研究 [J]. 肿瘤防治研究, 2006(1):5.doi: 10.3971/j.issn.1000-8578.2006.01.002.
|
王水利, 王茁, 罗小峰. 小细胞肺癌患者血清血管内皮生长因子含量水平的临床意义 [J]. 现代肿瘤医学, 2006(7):810.doi: 10.3969/j.issn.1672-4992.2006.07.013.
|
赵军, 刘叙仪, 张青云. 晚期非小细胞肺癌患者外周血VEGF和bFGF及MMP-9水平与预后的关系 [J]. 中华肿瘤杂志, 2005, (11):676.doi: 10.3760/j.issn:0253-3766.2005.11.010.
|
Brattstrom D, Bergqvist M, Hesselius P. Elevated preoperative serum levels of angiogenic cytokines correlate to larget primary tumours and poorer survival in non-small cell lung cancer patients [J]. Lung Cancer, 2002(1):57.doi: 10.1016/S0169-5002(02)00027-2.
|
刘玉春, 林士军, 董惠翔. 肺癌血清血管内皮生长因子水平与分期及预后的关系 [J]. 中国肿瘤, 2005(3):196.doi: 10.3969/j.issn.1004-0242.2005.03.018.
|
Matsuyama W, Hashiguchi T, Mizognchi A. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer [J]. Chest, 2001(4):948.
|
Arinaga M, Noguchi T, Takeno S. Clinial significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with non-small cell lung carcinoma [J]. Cancer, 2003, (2):457.doi: 10.1002/cncr.11073.
|
MineoT C, Ambrogi V, Baldi A. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer [J]. Journal of Clinical Pathology, 2004.591.
|
Eckart L, Antje S, Iris B. Pretreatment vascular endothelial growth factor(VEGF)and matrix metalloproteinase-9(MMP-9)serum levels in patients with metastatic nonsmall lung cancer(NSCLC) [J]. Lung Cancer, 2005, (1):51.doi: 10.1016/j.lungcan.2005.05.011.
|
Brattstrom D, Bergqvist M, Hesseliusp. Serum VEGF and bFGF adds prognostic in-formation in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer [J]. Lung Cancer, 2004, (1):55.doi: 10.1016/j.lungcan.2003.07.007.
|
Ravi R, Mookerjee B, Bhujwalla Z M. Regulation oftumor angiogenesis by p532induced degradation of hypoxiainducible factor lalpha [J]. Genes and Development, 2000.342.
|
Salven P, Orpana A, Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor [J]. Clinical Cancer Research, 1999.487.
|
Verheul H, Hoekman K, Luykx-de Bakker S. Platelet:transporter of vascular endothelial growth factor [J]. Clinical Cancer Research, 1997.2187.
|
Liao M, Wang H, Lin Z. Vaseulr endothelial growth factor and other biological predictors related to the post-operative survival rate on nnon-small cell lung cancer [J]. Lung Cancer, 2001.125.doi: 10.1016/S0169-5002(01)00195-7.
|
Baillie R, Carlile J, Pendleton N. Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer [J]. Journal of Clinical Pathology, 2001.116.doi: 10.1136/jcp.54.2.116.
|
Choi J H, Kim H C, Lim H Y. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer:correlation with platelet and leukocyte counts [J]. Lung Cancer, 2001.171.doi: 10.1016/S0169-5002(01)00200-8.
|
孔德勇, 卢忠心. 肺癌患者血清中血管内皮生长因子的表达及其临床意义 [J]. 临床血液学杂志, 2007(5):208.doi: 10.3969/j.issn.1004-2806-B.2007.05.006.
|
Jelkmann W. Pitfalls in the measurement of circu-lating vascular endothelial growth factor [J]. Clinical Chemistry, 2001.617.
|
Salven P, Orpana A, Joensuu H. Leuko-cytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor [J]. Clinical Cancer Research, 1999.487.
|